STOCK TITAN

If You Invested in Multiplan Corporation (MPLN)

Services-business Services, Nec · Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) · NYSE
Looking for the current price? See the MPLN quote & overview
$1,000 invested 1 Year Ago
N/A
Trading since 2020-04-06
$1,000 invested 5 Years Ago
$96
-90.4% total -48.5% CAGR
Bought on Aug 18, 2021 at $240.00

What $1,000 or $10,000 in MPLN Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Apr 6, 2020
$1,000 $96 -90% $60 -94%
$10,000 $965 -90% $595 -94%

Based on real historical closing prices, dividend- and split-adjusted, through 2025-02-27. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for MPLN

$1,000 Investment Over Time

MPLN vs S&P 500

Year-by-Year Returns

MPLN annual performance
Year Start Price End Price Annual Return Cumulative
2020 $388.80 $319.60 -17.8% -17.8%
2021 $316.80 $177.20 -44.1% -54.4%
2022 $179.60 $46.00 -74.4% -88.2%
2023 $41.60 $57.60 +38.5% -85.2%
2024 $54.80 $14.78 -73.0% -96.2%
2025 $12.95 $23.15 +78.8% -94.0%

About Multiplan Corporation

Services-business Services, Nec · NYSE

MPLN historically represented MultiPlan Corporation on the New York Stock Exchange. According to subsequent company communications and SEC filings, MultiPlan has undergone a corporate rebrand and now operates as Claritev Corporation, a healthcare technology, data and insights company. Claritev focuses on delivering affordability, transparency and quality to the U.S. healthcare system by using technology, data analytics and AI-driven insights. While the company’s corporate name and trading symbol have changed, MPLN remains the historical ticker associated with MultiPlan’s earlier public-market history.

Business focus and role in healthcare

Claritev, formerly known as MultiPlan, is described in multiple press releases as a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all. The company emphasizes the use of sophisticated technology, data analytics and a large base of claims processing data accumulated over more than 40 years. Its services are aimed at identifying healthcare cost savings, lowering out-of-pocket costs and reducing or eliminating balance bills for patients in the U.S. healthcare system.

Claritev’s platform is characterized as an enterprise environment that applies data and AI to drive affordability and price transparency and to optimize networks and benefits design in healthcare. Company descriptions note that Claritev supports a broad set of stakeholders across the healthcare ecosystem, including payors, employers, patients, providers and third parties. In various releases, the company highlights that it delivers value to more than 700 healthcare payors, over 100,000 employers, 60 million consumers and 1.4 million contracted providers.

Evolution from MultiPlan to Claritev

In a corporate rebranding announcement, the company stated that MultiPlan is now Claritev and that it would begin trading under a new ticker, CTEV, on the New York Stock Exchange. The release explains that the business was founded in 1980 and initially operated as a New York-based hospital network. Over time, it expanded into a national organization delivering technology, data analytics and solutions that support affordability, transparency and quality in healthcare. The rebrand to Claritev is framed as reflecting increased investment, transformation and a commitment to bringing transparency to a broader portion of the healthcare ecosystem.

The company notes that the rebrand marks a pivotal point in its strategic transformation and mission to support the healthcare continuum. It also states that the rebrand will have no impact on its existing suite of offerings, indicating continuity in the underlying services even as the corporate identity and ticker symbol change. For investors researching MPLN, this means that historical references to MultiPlan’s services, customer base and role in healthcare are now part of Claritev’s corporate history.

Technology, data and AI capabilities

Claritev’s public descriptions emphasize the use of technology and data to power its offerings. The company states that it leverages world-class technology and AI to operate a robust enterprise platform. This platform is described as delivering meaningful insights that drive affordability and price transparency and that help optimize networks and benefits design in healthcare. The company also highlights the use of data and decision science and analytics-based services as part of its approach.

In connection with its digital transformation, MultiPlan announced that it would consolidate its cloud infrastructure on Oracle Cloud Infrastructure. The company indicated that this move is intended to support its transformation, improve efficiency and create a more flexible infrastructure that can meet evolving market demands. It described the Oracle Cloud environment as a foundation that can help it bring new products to market faster and better support clients with solutions that improve affordability, quality and transparency.

Networks, cost management and ecosystem reach

Company materials describe a significant role in delivering access to care through provider networks and in identifying healthcare cost savings. Claritev reports that it contracts with over 1.4 million healthcare providers and serves more than 700 healthcare payors and over 100,000 employers. It cites experience in identifying substantial potential medical cost savings on behalf of payors and their employer customers.

The company’s services are described as supporting network-based solutions, payment and revenue integrity, and data and decision science capabilities. In a strategic agreement announcement with J2 Health, MultiPlan explained that it uses network and data services to help payors improve network adequacy, marketability and accuracy. The agreement is presented as a way to enhance network configuration, transparency and analytics capabilities, with the goal of reducing healthcare costs for payors and supporting better pricing outcomes.

Products and partnerships highlighted in public materials

Claritev has highlighted specific offerings and partnerships that illustrate how its data and technology are applied. In collaboration with Oracle, the company announced that its analytics solution, BenInsights, is powered by Oracle Cloud and available in the Oracle Cloud Marketplace. BenInsights is described as an analytics platform that provides visibility into benefit plan performance and compliance responsibilities for employers. Integrated with Oracle Cloud, it offers configurable automated reports and analytics intended to support benefits management, cost containment and monitoring of plan performance.

In another announcement, ClearNote Health referenced Claritev’s national PHCS and MultiPlan Networks in connection with access to an early detection pancreatic cancer test. This illustrates how Claritev’s provider networks can be used to expand access to specific healthcare services for health plan members. Across these communications, Claritev positions its networks, data and analytics as tools that can support multiple stakeholders in the healthcare system.

Corporate identity and trading symbol

While MPLN was the ticker symbol historically associated with MultiPlan Corporation, more recent SEC filings and press releases refer to Claritev Corporation and indicate that the company’s Class A common stock trades on the New York Stock Exchange under the symbol CTEV. The filings identify Claritev Corporation as a Delaware corporation and refer to Claritev and its consolidated subsidiaries collectively as the company.

For users researching MPLN stock, this context means that MPLN represents the earlier ticker for the same underlying corporate group that now operates and files reports as Claritev under the symbol CTEV. Historical information, such as earlier earnings releases, refinancing announcements and transformation plans, may still reference the MultiPlan name and MPLN symbol, but subsequent materials and SEC filings use the Claritev name and updated ticker.

Capital structure and transformation initiatives

MultiPlan and Claritev have publicly discussed a multi-year transformation plan, sometimes referred to as a Vision 2030 plan, aimed at evolving into a data and technology-forward health technology organization. As part of this transformation, the company has announced a series of refinancing transactions designed to extend the maturities of its debt capital structure. Press releases describe exchange offers and consent solicitations involving senior secured notes, senior notes, convertible notes and term loans, with the goal of reorganizing the capital structure and supporting long-term growth.

The company has reported high levels of participation from existing noteholders and lenders in these exchange offers and has highlighted the role of these transactions in freeing internal resources to focus on its transformation journey. These communications present the refinancing as a way to support continued investment in technology, data infrastructure and product development aligned with the company’s healthcare affordability and transparency mission.

Geographic and regulatory context

SEC filings identify Claritev Corporation as a Delaware corporation with securities registered under Section 12(b) of the Securities Exchange Act of 1934. The filings list shares of Class A common stock with a par value of $0.0001 per share trading on the New York Stock Exchange under the symbol CTEV. The company operates within the U.S. healthcare system and positions its technology, data and insights to address affordability, transparency and quality for U.S. healthcare stakeholders.

Because MPLN has transitioned to CTEV as the active trading symbol, investors and researchers looking for the most recent corporate disclosures, financial results and strategic updates should review materials filed and released under the Claritev name and CTEV ticker. The MPLN symbol and MultiPlan name remain relevant for understanding the company’s historical development, earlier capital structure and the origins of its transformation into Claritev.

Market Cap
$0.3B
Current Price
$23.15
View full MPLN overview

Frequently Asked Questions

Multiplan Corporation investment returns

How much would $1,000 invested in Multiplan Corporation be worth today?

If you invested $1,000 in Multiplan Corporation (MPLN) 5 years ago on 2021-08-18, your investment would be worth $96 as of 2025-02-27, representing a -90.4% total return, growing at a compounded rate of -48.5% per year (CAGR).

Has Multiplan Corporation outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare MPLN performance over available time periods.

What is Multiplan Corporation's average annual return?

The compound annual growth rate (CAGR) of MPLN over the past 5 years is -48.5%, growing at a compounded rate each year. Individual years vary significantly — MPLN's best recent year was 2025 (+78.8%) and worst was 2022 (-74.4%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.